Relebactam sodium is a synthetic beta-lactamase inhibitor that is primarily used in combination with certain antibiotics to enhance their efficacy against resistant bacterial strains. It is particularly effective against a range of beta-lactamase enzymes produced by bacteria, which can inactivate many penicillins and cephalosporins. The compound is characterized by its ability to restore the activity of these antibiotics against resistant pathogens, making it a valuable tool in the treatment of complicated infections. Relebactam sodium is typically administered intravenously and is known for its favorable pharmacokinetic properties, allowing for effective dosing regimens. In terms of safety, it has been evaluated in clinical trials, demonstrating a tolerable side effect profile. The compound's mechanism of action involves binding to the active site of beta-lactamases, preventing them from hydrolyzing the beta-lactam ring of antibiotics. Overall, Relebactam sodium represents a significant advancement in the fight against antibiotic resistance, particularly in the context of multidrug-resistant infections.

Relebactam sodium

1502858-91-4: Relebactam sodium is a synthetic beta-lactamase inhibitor that is primarily used in combination with certain antibiotics to enhance their efficacy against resistant bacterial strains. It is particularly effective against a range of beta-lactamase enzymes produced by bacteria, which can inactivate many penicillins and cephalosporins. The compound is characterized by its ability to restore the activity of these antibiotics against resistant pathogens, making it a valuable tool in the treatment of complicated infections. Relebactam sodium is typically administered intravenously and is known for its favorable pharmacokinetic properties, allowing for effective dosing regimens. In terms of safety, it has been evaluated in clinical trials, demonstrating a tolerable side effect profile. The compound's mechanism of action involves binding to the active site of beta-lactamases, preventing them from hydrolyzing the beta-lactam ring of antibiotics. Overall, Relebactam sodium represents a significant advancement in the fight against antibiotic resistance, particularly in the context of multidrug-resistant infections.

Relebactam sodium is a potent and selective β-lactamase inhibitor.

CAS 1502858-91-4

Relebactam sodium

Relebactam sodium

Ref: TM-T70530